换一批
换一批Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
作者：
Marcelo,Sobral-Leite [1]
;
Jelle,Wesseling [2]
;
Vincent T H B M,Smit [3]
;
Heli,Nevanlinna [4]
;
Martine H,van Miltenburg [5]
;
Joyce,Sanders [6]
;
Ingrid,Hofland [7]
;
Fiona M,Blows [8]
;
Penny,Coulson [9]
;
Gazinska,Patrycja [10]
;
Jan H M,Schellens [11]
;
Rainer,Fagerholm [12]
;
Päivi,Heikkilä [13]
;
Kristiina,Aittomäki [14]
;
Carl,Blomqvist [15]
;
Elena,Provenzano [16]
;
Hamid Raza,Ali [17]
;
Jonine,Figueroa [18]
;
Mark,Sherman [19]
;
Jolanta,Lissowska [20]
;
Arto,Mannermaa [21]
;
Vesa,Kataja [22]
;
Veli-Matti,Kosma [23]
;
Jaana M,Hartikainen [24]
;
Kelly-Anne,Phillips [25]
;
kConFab/AOCS Investigators [26]
;
Fergus J,Couch [27]
;
Janet E,Olson [28]
;
Celine,Vachon [29]
;
Daniel,Visscher [30]
;
Hermann,Brenner [31]
;
Katja,Butterbach [32]
;
Volker,Arndt [33]
;
Bernd,Holleczek [34]
;
Maartje J,Hooning [35]
;
Antoinette,Hollestelle [36]
;
John W M,Martens [37]
;
Carolien H M,van Deurzen [38]
;
Bob,van de Water [39]
;
Annegien,Broeks [40]
;
Jenny,Chang-Claude [41]
;
Georgia,Chenevix-Trench [42]
;
Douglas F,Easton [43]
;
Paul D P,Pharoah [44]
;
Montserrat,García-Closas [45]
;
Marjo,de Graauw [46]
;
Marjanka K,Schmidt [47]
作者单位：
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.leite@nki.nl.
[1]
Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. m.leite@nki.nl.
[2]
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl.
[3]
Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl.
[4]
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. V.T.H.B.M.Smit@lumc.nl.
[5]
University of Helsinki, Helsinki, Finland. Heli.Nevanlinna@hus.fi.
[6]
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. Heli.Nevanlinna@hus.fi.
[7]
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.v.miltenburg@nki.nl.
[8]
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. jo.sanders@nki.nl.
[9]
Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. i.hofland@nki.nl.
[10]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. fmb28@medschl.cam.ac.uk.
[11]
Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. Penny.Coulson@icr.ac.uk.
[12]
Breakthrough Breast Cancer Centre, London, UK. patrycja.gazinska@kcl.ac.uk.
[13]
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.schellens@nki.nl.
[14]
Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. j.schellens@nki.nl.
[15]
University of Helsinki, Helsinki, Finland. rainer.fagerholm@helsinki.fi.
[16]
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. rainer.fagerholm@helsinki.fi.
[17]
University of Helsinki, Helsinki, Finland. paivi.heikkila@hus.fi.
[18]
Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. paivi.heikkila@hus.fi.
[19]
University of Helsinki, Helsinki, Finland. kristiina.aittomaki@helsinki.fi.
[20]
Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. kristiina.aittomaki@helsinki.fi.
[21]
University of Helsinki, Helsinki, Finland. carl.blomqvist@helsinki.fi.
[22]
Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. carl.blomqvist@helsinki.fi.
[23]
Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.
[24]
Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.
[25]
Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. Raza.Ali@cruk.cam.ac.uk.
[26]
Department of Pathology, University of Cambridge, Cambridge, UK. Raza.Ali@cruk.cam.ac.uk.
[27]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. figueroaj@mail.nih.gov.
[28]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. shermanm@exchange.nih.gov.
[29]
Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. shermanm@exchange.nih.gov.
[30]
Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. lissowsj@coi.waw.pl.
[31]
School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.
[32]
Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.
[33]
Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. arto.mannermaa@uef.fi.
[34]
Cancer Center, Kuopio University Hospital, Kuopio, Finland. vesa.kataja@ksshp.fi.
[35]
Jyväskylä Central Hospital, Jyväskylä, Finland. vesa.kataja@ksshp.fi.
[36]
School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.
[37]
Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.
[38]
Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. veli-matti.kosma@uef.fi.
[39]
School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.
[40]
Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.
[41]
Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. jaana.hartikainen@uef.fi.
[42]
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. Kelly.Phillips@petermac.org.
[43]
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.
[44]
Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.
[45]
Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.
[46]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. couch.fergus@mayo.edu.
[47]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. olsonj@mayo.edu.
[48]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. vachon.celine@mayo.edu.
[49]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. visscher.daniel@mayo.edu.
[50]
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.
[51]
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.
[52]
Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.
[53]
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. k.butterbach@dkfz.de.
[54]
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. v.arndt@dkfz.de.
[55]
Saarland Cancer Registry, Saarbrücken, Germany. B.Holleczek@gbe-ekr.saarland.de.
[56]
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.hooning@erasmusmc.nl.
[57]
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl.
[58]
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. j.martens@erasmusmc.nl.
[59]
Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. c.h.m.vandeurzen@erasmusmc.nl.
[60]
Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.
[61]
Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. a.broeks@nki.nl.
[62]
Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.chang-claude@dkfz-heidelberg.de.
[63]
Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Georgia.Trench@qimrberghofer.edu.au.
[64]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
[65]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. paul.pharoah@srl.cam.ac.uk.
[66]
Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. Montse.GarciaClosas@icr.ac.uk.
[67]
Breakthrough Breast Cancer Centre, London, UK. Montse.GarciaClosas@icr.ac.uk.
[68]
Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. m.de.graauw@lacdr.leidenuniv.nl.
[69]
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
[70]
Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
[71]
主题词
成年人(Adult);膜联蛋白A1(Annexin A1);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);基因, BRCA1(Genes, BRCA1);基因, BRCA2(Genes, BRCA2);疾病遗传易感性(Genetic Predisposition to Disease);人类(Humans);免疫组织化学(Immunohistochemistry);中年人(Middle Aged);突变(Mutation);预后(Prognosis)
DOI
10.1186/s12916-015-0392-6
PMID
26137966
发布时间
2024-02-10
- 浏览21
BMC medicine
156页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
